Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2061)
All Articles published online
|
Feb 7, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nahon P, Sutton A, Rufat P, Simon C, Trinchet JC, Gattegno L, Beaugrand M, Charnaux N. Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. World J Gastroenterol 2008; 14(5): 713-719 [PMID: 18205260 DOI: 10.3748/wjg.14.713] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i5/713.htm |
| Number | Citing Articles |
| 1 |
Greta Pessino, Claudia Scotti, Maristella Maggi. Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets. Cancers 2024; 16(5): 901 doi: 10.3390/cancers16050901
|
| 2 |
Hossein Khorramdelazad, Elham Hakimizadeh, Gholamhossein Hassanshahi, Mohammadtaghi Rezayati, Hossein Sendi, Mohammad Kazemi Arababadi. CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection. Journal of Medical Virology 2013; 85(6): 964 doi: 10.1002/jmv.23510
|
| 3 |
Khadija Rebbani, Sayeh Ezzikouri, Agnès Marchio, Mostafa Ababou, Bouchra Kitab, Anne Dejean, Mostafa Kandil, Pascal Pineau, Soumaya Benjelloun. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population. Infection, Genetics and Evolution 2014; 26: 1 doi: 10.1016/j.meegid.2014.04.019
|
| 4 |
Trina J Stewart, Mark J Smyth. Chemokine–Chemokine Receptors in Cancer Immunotherapy. Immunotherapy 2009; 1(1): 109 doi: 10.2217/1750743X.1.1.109
|
| 5 |
Alicja E. Grzegorzewska, Adrianna Mostowska. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_8-1
|
| 6 |
Erinaldo Ubirajara Damasceno dos Santos, Géssica Dayane Cordeiro de Lima, Micheline de Lucena Oliveira, Sandra de Andrade Heráclio, Hildson Dornelas Angelo da Silva, Sergio Crovella, Maria de Mascena Diniz Maia, Paulo Roberto Eleutério de Souza/. CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study. Memórias do Instituto Oswaldo Cruz 2016; 111(3): 174 doi: 10.1590/0074-02760150367
|
| 7 |
Dennis A. Smith, Anthony Harrison, Paul Morgan. Multiple Factors Govern the Association between Pharmacology and Toxicity in a Class of Drugs: Toward a Unification of Class Effect Terminology. Chemical Research in Toxicology 2011; 24(4): 463 doi: 10.1021/tx100408v
|
| 8 |
Hongxia Ma, Yongqian Shu, Shiyang Pan, Jiaping Chen, Juncheng Dai, Guangfu Jin, Zhibin Hu, Hongbing Shen. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese. Lung Cancer 2011; 74(2): 164 doi: 10.1016/j.lungcan.2011.03.005
|
| 9 |
Mohammad Kazemi Arababadi, Ali Akbar Pourfathollah, Abdollah Jafarzadeh, Gholamhossein Hassanshahi, Maryam Mohit, Masomeh Hajghani, Behzad Nasiri Ahmadabadi, Derek Kennedy. Evaluation of CCR5 Expression on NK Cells in Iranian Patients With Occult Hepatitis B Infection. Laboratory Medicine 2010; 41(12): 735 doi: 10.1309/LMAUISL84Q4SRSBT
|
| 10 |
Ting Liu, Jin-Xia Zhai, Han-Yong Wang, Xing-Hua Wang, Li-Wei Zou, Wen-jing Fan, Dong-Qing Ye. Meta-analysis of MCP-1 promoter −2518 A/G polymorphism and SLE susceptibility. Molecular Biology Reports 2012; 39(8): 8475 doi: 10.1007/s11033-012-1701-1
|
| 11 |
Maylis Dagouassat, Nadine Suffee, Hanna Hlawaty, Oualid Haddad, Faten Charni, Christelle Laguillier, Roger Vassy, Loïc Martin, Pierre‐Olivier Schischmanoff, Liliane Gattegno, Olivier Oudar, Angela Sutton, Nathalie Charnaux. Monocyte chemoattractant protein‐1 (MCP‐1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells. International Journal of Cancer 2010; 126(5): 1095 doi: 10.1002/ijc.24800
|
| 12 |
Khodayar Ghorban, Maryam Dadmanesh, Gholamhossein Hassanshahi, Mohammad Momeni, Mohammad Zare-Bidaki, Mohammad Kazemi Arababadi, Derek Kennedy. Is the CCR5 Δ 32 Mutation Associated with Immune System-Related Diseases?. Inflammation 2013; 36(3): 633 doi: 10.1007/s10753-012-9585-8
|
| 13 |
Mohammad Kazemi Arababadi, Ali Akbar Pourfathollah, Abdollah Jafarzadeh, Gholamhossein Hassanshahi, Maryam Mohit, Masomeh Hajghani, Ali Shamsizadeh. Peripheral Blood CD8+T Cells CCR5 Expression and Its Δ32 Mutation in Iranian Patients with Occult Hepatitis B Infections. Laboratory Medicine 2010; 41(4): 226 doi: 10.1309/LMVUKWROX0EBQR01
|
| 14 |
Alicja E. Grzegorzewska, Monika K. Świderska, Adrianna Mostowska, Paweł P. Jagodziński. Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/3713025
|
| 15 |
Makoto Chuma, Haruki Uojima, Hidenori Toyoda, Atsushi Hiraoka, Yoshitake Arase, Masanori Atsukawa, Norio Itokawa, Tomomi Okubo, Toshifumi Tada, Kazushi Numata, Manabu Morimoto, Makoto Sugimori, Akito Nozaki, Shuichiro Iwasaki, Satoshi Yasuda, Yuichi Koshiyama, Yusuke Mishima, Kota Tsuruya, Chikako Tokoro, Yuki Miura, Hisashi Hidaka, Takashi Kumada, Chika Kusano, Tatehiro Kagawa, Shin Maeda. Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma. Hepatology International 2024; 18(5): 1472 doi: 10.1007/s12072-024-10680-8
|
| 16 |
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron Metabolism. Cytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
|
| 17 |
Yan Wang, Xiao-Ai Zhang, Xiao Yang, Zhi-Hao Wu, Zhi-Chun Feng.
A MCP-1 promoter polymorphism at G-2518A is associated with spontaneous preterm birth. Molecular Genetics and Genomics 2015; 290(1): 289 doi: 10.1007/s00438-014-0921-6
|
| 18 |
Alicja E. Grzegorzewska, Adrianna Mostowska. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 927 doi: 10.1007/978-94-007-7675-3_8
|
| 19 |
EMMANOUIL LIARMAKOPOULOS, GEORGE THEODOROPOULOS, ANNA VAIOPOULOU, SPYROS RIZOS, GERASIMOS ARAVANTINOS, GREGORY KOURAKLIS, NIKOLAOS NIKITEAS, MARIA GAZOULI. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk. Molecular Medicine Reports 2013; 7(3): 887 doi: 10.3892/mmr.2012.1247
|
| 20 |
Meenakshi Sachdeva, Yogesh K Chawla, Sunil K Arora. Immunology of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(17): 2080-2090 doi: 10.4254/wjh.v7.i17.2080
|
| 21 |
Sulemon Chaudhry, Jean Emond, Adam Griesemer. Immune Cell Trafficking to the Liver. Transplantation 2019; 103(7): 1323 doi: 10.1097/TP.0000000000002690
|
| 22 |
Chun-Min Liang, Long Chen, Heng Hu, Hui-Ying Ma, Ling-Ling Gao, Jie Qin, Cui-Ping Zhong. Chemokines and their receptors play important roles in the development of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(10): 1390-1402 doi: 10.4254/wjh.v7.i10.1390
|
| 23 |
M Sadeghi, I Lahdou, H Oweira, V Daniel, P Terness, J Schmidt, K-H Weiss, T Longerich, P Schemmer, G Opelz, A Mehrabi. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. British Journal of Cancer 2015; 113(5): 756 doi: 10.1038/bjc.2015.227
|
| 24 |
Łukasz Kruszyna, Margarita Lianeri, Błażej Rubis, Hanna Knuła, Maria Rybczyńska, Sylwia Grodecka-Gazdecka, Paweł P. Jagodziński. CCL2 −2518 A/G single nucleotide polymorphism as a risk factor for breast cancer. Molecular Biology Reports 2011; 38(2): 1263 doi: 10.1007/s11033-010-0225-9
|
| 25 |
Hossein Khorramdelazad, Yousef Mortazavi, Mohammad Momeni, Mohammad Kazemi Arababadi, Behjat Kalantary Khandany, Mozhgan Moogooei, Gholamhossein Hassanshahi. Lack of Correlation Between the CCR5-Δ32 Mutation and Acute Myeloid Leukemia in Iranian Patients. Indian Journal of Hematology and Blood Transfusion 2015; 31(1): 29 doi: 10.1007/s12288-014-0408-y
|
| 26 |
Canan Kucukgergin, Ferruh K. Isman, Bedia Cakmakoglu, Oner Sanli, Sule Seckin. Association of Polymorphisms inMCP-1, CCR2,andCCR5Genes with the Risk and Clinicopathological Characteristics of Prostate Cancer. DNA and Cell Biology 2012; 31(8): 1418 doi: 10.1089/dna.2012.1716
|
| 27 |
Xing-Zhizi Wang, Xiao-Ying Huang, Jin-Guang Yao, Chao Wang, Qiang Xia, Xi-Dai Long. Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1. Oncotarget 2018; 9(44): 27321 doi: 10.18632/oncotarget.24535
|
| 28 |
Chao‐Bin Yeh, Hsiu‐Ting Tsai, Yi‐Chen Chen, Wu‐Hsien Kuo, Tzy‐Yen Chen, Yi‐Hsien Hsieh, Ming‐Chih Chou, Shun‐Fa Yang. Genetic polymorphism of CCR2‐64I increased the susceptibility of hepatocellular carcinoma. Journal of Surgical Oncology 2010; 102(3): 264 doi: 10.1002/jso.21623
|
| 29 |
Pierre Nahon, Jessica Zucman-Rossi. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. Journal of Hepatology 2012; 57(3): 663 doi: 10.1016/j.jhep.2012.02.035
|
| 30 |
Asmaa M. Zahran, Helal F. Hetta, Amal Rayan, Abeer Sharaf Eldin, Elham Ahmed Hassan, Hussein Fakhry, Ahmed Soliman, Omnia El-Badawy. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes. Cancer Immunology, Immunotherapy 2020; 69(7): 1253 doi: 10.1007/s00262-019-02465-y
|
| 31 |
Vasudha Sambyal, Kamlesh Guleria, Ruhi Kapahi, Mridu Manjari, Meena Sudan, Manjit Singh Uppal, Neeti Rajan Singh. Association of the -2518 A/G Polymorphism of MCP-1 with Breast Cancer in Punjab, North-West India. Asian Pacific Journal of Cancer Prevention 2015; 16(16): 7243 doi: 10.7314/APJCP.2015.16.16.7243
|
| 32 |
Santosh K. Singh, Manoj K. Mishra, Brian M. Rivers, Jennifer B. Gordetsky, Sejong Bae, Rajesh Singh. Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma. Cancers 2020; 12(4): 883 doi: 10.3390/cancers12040883
|
| 33 |
Chi-Chung Chang, Shu-Chen Chen, Yi-Hsien Hsieh, Yi-Chen Chen, Tzy-Yen Chen, Yin-Hung Chu, Hui-Jen Ma, Ming-Chih Chou, Hsiu-Ting Tsai, Shun-Fa Yang. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clinical Chemistry and Laboratory Medicine 2009; 47(4) doi: 10.1515/CCLM.2009.092
|